H
Henry R. Black
Researcher at Rush University Medical Center
Publications - 207
Citations - 92296
Henry R. Black is an academic researcher from Rush University Medical Center. The author has contributed to research in topics: Blood pressure & Prehypertension. The author has an hindex of 74, co-authored 206 publications receiving 88350 citations. Previous affiliations of Henry R. Black include University of Erlangen-Nuremberg.
Papers
More filters
Journal ArticleDOI
Antihypertensive therapy, the α-adducin polymorphism, and cardiovascular disease in high-risk hypertensive persons: the Genetics of Hypertension-Associated Treatment Study
Barry R. Davis,Donna K. Arnett,Eric Boerwinkle,Charles E. Ford,C. Leiendecker-Foster,Michael B. Miller,Henry R. Black,John H. Eckfeldt +7 more
TL;DR: The α-adducin gene is not an important modifier of antihypertensive treatment on cardiovascular risk, but women Trp allele carriers may have increased CHD risk if treated with C versus A or L.
Journal ArticleDOI
Left ventricular systolic performance during upright bicycle exercise in patients with essential hypertension
Charles K. Francis,Michael W. Cleman,H J Berger,Ross A. Davies,Robert W. Giles,Henry R. Black,Nestor A. Vita,Ruben A. Zito,Barry L. Zaret +8 more
TL;DR: In most patients with essential hypertension but without concomitant coronary artery disease, left ventricular reserve during exercise was normal, and hypertension should not be viewed as the cause for an abnormalleft ventricular response to exercise in a patient undergoing diagnostic exercise radionuclide angiocardiography.
Journal ArticleDOI
Guidelines for Hypertension: Are Quality-Assurance Measures on Target?
TL;DR: Although goal was achievable in most uncomplicated hypertension, hypertension in diabetes was more difficult to control, despite being more likely to receive enhanced benefit from effective management, and should be aggressively sought rather than relaxing goals to promote achievement.
Journal ArticleDOI
The evolution of low-dose diuretic therapy: the lessons from clinical trials.
TL;DR: The development of antihypertensive therapy is traced and how data from clinical trials have influenced the recommendations of the Joint National Committees on the Detection, Evaluation and Treatment of Hypertension is reviewed.
Journal ArticleDOI
Angiotensin-Converting Enzyme Inhibitor Use and Incident Frailty in Women Aged 65 and Older: Prospective Findings from the Women's Health Initiative Observational Study
Shelly L. Gray,Andrea Z. LaCroix,Aaron K. Aragaki,Mary M. McDermott,Barbara B. Cochrane,Charles Kooperberg,Anne M. Murray,Beatriz Rodriguez,Henry R. Black,Nancy Fugate Woods +9 more
TL;DR: In this paper, the authors examined the associations between current use, duration, and potency of ACE inhibitors and incident frailty in women ages 65 and older who were not frail at baseline, using data from the Women's Health Initiative Observational Study (WHI-OS).